The first signs that H5N1 avian flu was starting to spread from person to person would trigger a race to produce massive ...

By the time you reach the end of this article, three children will have died from malaria – a disease that casts a dark ...

Until three years ago nobody had developed a vaccine against any parasitic disease. Now there are two against malaria: the ...

An early-stage clinical trial yielded promising results for a chlamydia vaccine, researchers reported Thursday in The Lancet ...

After AstraZeneca’s recent acquisitions of various technologies across different therapeutic areas, some investors started to ...

Driven by the overuse of antimicrobials, pathogens are quickly building up resistances to once-successful treatments. It's ...

A Chlamydia vaccine showed promising results in an early-stage clinical trial conducted by researchers in the U.K. and ...

She’s the director of UW Medicine’s Cancer Vaccine Institute and has studied the development of cancer vaccines. She says we ...

A chlamydia vaccine has triggered immune responses in an early trial, raising hopes that one day it might help curb the ...

A team of Montana researchers is playing a key role in the development of a more effective vaccine against tuberculosis, an ...

These vaccines might also be more effective than what we have right now. Several are undergoing phase 3 trials — the last step before vaccine makers can apply to international and national ...

A 100% fourfold seroconversion rate occurred in all groups receiving CTH522, a recombinant vaccine containing the major outer ...